The Knee
Volume 17, Issue 3 , Pages 252-254 , June 2010

Total knee arthroplasty and Crigler–Najjar syndrome: A case report

  • David Walmsley

      Affiliations

    • Division of Orthopedic Surgery, Department of Surgery, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, Canada, M5T 2S8
    • ,
  • Khalid Alzaharani

      Affiliations

    • Division of Orthopedic Surgery, Department of Surgery, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, Canada, M5T 2S8
    • ,
  • William J. Coke

      Affiliations

    • Department of Medicine, University of Toronto, Toronto General Hospital, Toronto, ON, Canada, M5G 2C4
    • ,
  • Rajiv Gandhi

      Affiliations

    • Division of Orthopedic Surgery, Department of Surgery, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, Canada, M5T 2S8
    • Corresponding Author InformationCorresponding author. Tel.: +1 416 603 5642; fax: +1 416 603 3437.

Received 6 April 2009 ,Revised 21 August 2009 ,Accepted 25 August 2009.

References 

  1. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem. 1994;269:17960
  2. Jansen PL. Diagnosis and management of Crigler–Najjar syndrome. Eur J Pediatr. 1999;158(Suppl 2):S89
  3. Cashore WJ. Kernicterus and bilirubin encephalopathy. Semin Liver Dis. 1988;8:163
  4. Brito MA, Lima S, Fernandes A, Falcao AS, Silva RF, Butterfield DA, et al. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology. 2008;29:259
  5. Vassilopoulou-Sellin R, Oyedeji CO. Tetrapyrroles as inhibitors of normal cartilage metabolism: relative potency of different compounds. J Bone Miner Res. 1988;3:681
  6. Vassilopoulou-Sellin R, Oyedeji CO, Samaan NA. Bilirubin inhibits cartilage metabolism and growth in vitro. Metabolism. 1989;38:759
  7. Vassilopoulou-Sellin R, Rey-Bear N, Oyedeji CO. Bilirubin as an inhibitor of cartilage metabolism: effect on avian chondrocyte proliferation in cell culture. J Bone Miner Res. 1990;5:769
  8. Landing BH. Yellow-orange intervertebral disks in chronic obstructive jaundice in children. Pediatr Pathol Lab Med. 1997;17:530
  9. Hough AJ, Banfield WG, Sokoloff L. Cartilage in hemophilic arthropathy. Ultrastructural and microanalytical studies. Arch Pathol Lab Med. 1976;100:91
  10. Robards C, Brull SJ. The anesthetic implications of Crigler–Najjar syndrome. Anesth Analg. 2007;104:435
  11. Brodersen R, Friis-Hansen B, Stern L. Drug-induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther. 1983;6:217
  12. Chalasani N, Chowdhury NR, Chowdhury JR, Boyer TD. Kernicterus in an adult who is heterozygous for Crigler–Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology. 1997;112:2099
  13. Van Thiel DH, Lester R. Postoperative jaundice: mechanism, diagnosis, and treatment. Surg Clin North Am. 1975;55:409
  14. Field E, Hors HM, Rubinfeld IS, Copeland CF, Waheed U, Jordan J, et al. Hyperbilirubinemia: a risk factor for infection in the surgical intensive care unit. Am J Surg. 2008;195:304
  15. Brito MA, Brites D, Butterfield DA. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res. 2004;1026:33
  16. Alexandra Brito M, Silva RF, Brites D. Bilirubin toxicity to human erythrocytes: a review. Clin Chim Acta. 2006;374:46

PII: S0968-0160(09)00166-5

doi: 10.1016/j.knee.2009.08.012

The Knee
Volume 17, Issue 3 , Pages 252-254 , June 2010

Article Tools

* Image Usage & Resolution